Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Fluorescein angiography of recurrent retinopathy of prematurity after initial intravitreous bevacizumab treatment.

× No keyword cloud information.

5 in total

1. [Pharmacological treatment for retinopathy of prematurity].

Authors: A Stahl; H Agostini; C Jandeck; W Lagrèze
Journal: Ophthalmologe Date: 2011-08 Impact factor: 1.059

2. Hyperoxia causes regression of vitreous neovascularization by downregulating VEGF/VEGFR2 pathway.

Authors: Hua Liu; Wenbo Zhang; Zhimin Xu; Robert W Caldwell; Ruth B Caldwell; Steven E Brooks
Journal: Invest Ophthalmol Vis Sci Date: 2013-02-01 Impact factor: 4.799

3. Anti-VEGF Agents for Ocular Angiogenesis and Vascular Permeability.

Authors: Kenichi Kimoto; Toshiaki Kubota
Journal: J Ophthalmol Date: 2011-11-03 Impact factor: 1.909

4. Intravitreal bevacizumab to treat retinopathy of prematurity in 865 eyes: a study to determine predictors of primary treatment failure and recurrence.

Authors: Kaveh Fadakar; Mohammadreza Mehrabi Bahar; Hamid Riazi-Esfahani; Afsaneh Azarkish; Afsar Dastjani Farahani; Mostafa Heidari; Fatemeh Bazvand
Journal: Int Ophthalmol Date: 2022-01-20 Impact factor: 2.029

Review 5. A Systematic Review and Meta-Analysis on the Safety of Vascular Endothelial Growth Factor (VEGF) Inhibitors for the Treatment of Retinopathy of Prematurity.

Authors: Laura Pertl; Gernot Steinwender; Christoph Mayer; Silke Hausberger; Eva-Maria Pöschl; Werner Wackernagel; Andreas Wedrich; Yosuf El-Shabrawi; Anton Haas
Journal: PLoS One Date: 2015-06-17 Impact factor: 3.240

5 in total